Piqray is a medication that is commonly prescribed to patients with advanced breast cancer that is hormone receptor-positive, human epidermal growth factor receptor 2-negative, and has a PIK3CA mutation. This oral medication is taken once daily at a dose of 250mg and works by inhibiting the PI3K pathway, which is often overactive in these types of breast cancer.

It is important to follow your healthcare provider’s instructions carefully when taking Piqray. It is typically recommended to take the medication at the same time each day with food to help reduce the risk of gastrointestinal side effects. Your healthcare provider may also monitor your blood sugar levels regularly while taking Piqray, as it can sometimes cause high blood sugar levels.

As with any medication, Piqray can cause side effects. Common side effects may include nausea, diarrhea, rash, and decreased appetite. It is important to report any side effects to your healthcare provider so they can help manage them and ensure that you are tolerating the medication well.

It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with Piqray. Additionally, women who are pregnant or breastfeeding should not take Piqray, as it may harm the developing fetus or nursing infant.

Overall, Piqray can be an effective treatment option for patients with advanced breast cancer that meets specific criteria. By working closely with your healthcare provider and following their guidance, you can help maximize the benefits of this medication while minimizing any potential risks.